Viewing nowLipistan Tablet (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.

MFDS item code 200402374 · Notified 2004.05.11 · Insurance code 698500090
Improves hyperlipidemia (including pediatric heterozygous familial hyperlipidemia) and prevents cardiovascular disease
This medication helps reduce the risk of serious events such as heart attack or stroke in adult patients at high risk for cardiovascular diseases like coronary artery disease, diabetes, peripheral vascular disease, and stroke. It also helps lower complications after cardiovascular surgery. Additionally, it effectively manages cholesterol and triglyceride levels in patients with primary hypercholesterolemia and dyslipidemia, supporting cardiovascular health. Especially in children over the age of 10 with a family history or belonging to high-risk groups for hypercholesterolemia, it is used as an adjunct to diet to assist in cholesterol management. This medication plays an important role in reducing cardiovascular disease risk and improving blood lipid levels.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. Administration of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate based on the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or more without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). 2) Refer below for recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see Precautions for Use, 6. Drug Interactions). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, administer 40 mg of this medicine once daily in the evening to patients with homozygous familial hypercholesterolemia. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not possible. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when administered alone or concomitantly with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine) and fenofibrate), the dose of this medicine must not exceed 10 mg per day. (6) Administration to patients with renal impairment As this medicine is not substantially excreted by the kidneys, dose adjustment is not necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg per day and monitor carefully.
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose individually according to the recommended treatment goals. Allow an interval of 4 weeks or longer between dose adjustments.
This medication carries the risk of serious side effects such as myopathy and rhabdomyolysis, particularly at high doses (80mg), so it is recommended that patients taking interacting medications use lower doses or different types of medications. It should not be used in certain patients, including those allergic to this medication or its components, those with severe liver dysfunction, pregnant or nursing women, and those taking certain antifungal or immunosuppressive agents. Patients with liver dysfunction or those who consume alcohol excessively, have renal impairment, have hypothyroidism, have muscle disorders, or have previously experienced muscle-related side effects, as well as elderly patients and women should use this medication cautiously and may need regular check-ups. During treatment, symptoms such as muscle pain, muscle weakness, abdominal pain, headache, dyspepsia, constipation, diarrhea, nausea may occur, and if any abnormal symptoms persist or worsen, a doctor should be consulted immediately. Since this medication is mainly metabolized in the liver, liver function tests should be conducted regularly, and if liver function abnormalities or jaundice occur, the medication should be discontinued. Several medications can increase the risk of myopathy when taken together, so it is essential to inform healthcare providers about this medication when starting any new medication. Women who are pregnant or may become pregnant should not take this medication and must stop and consult healthcare providers if they find out they are pregnant during use. Additionally, this medication can be excreted in breast milk, so nursing women should discontinue breastfeeding while taking this medication. Children and adolescents can only use it from age 10 and particularly females can only use it after at least one year since menarche. Elderly patients may have higher blood levels of this medication, which requires caution when taking it, as the risk of myopathy may also increase. Grapefruit juice or large amounts of grapefruit should be avoided during this treatment, and in case of overdose, immediate medical attention should be sought. Lastly, this medication should be kept out of the reach of children and stored tightly sealed in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius (room temperature) to ensure the medication's effectiveness.
Brownish-yellow oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.